Case Study: ZIOPHARM Oncology Inc

Abstract from ASCO presentation to be given on June 5, 2017

http://abstracts.asco.org/199/AbstView_199_190416.html

http://www.ziopharm.com/content/02-pipeline/03-presentations-publications/1-annual-meeting-american-society-of-clinical-oncology/2017-annual-meeting-american-society-of-clinical-oncology-asco/asco2017201700603final.pdf

https://finance.yahoo.com/news/ziopharm-oncology-announces-positive-updated-181500144.html

https://clinicaltrials.gov/show/NCT02026271

http://ir.ziopharm.com/releasedetail.cfm?ReleaseID=1029071

http://www.ziopharm.com/content/02-pipeline/03-presentations-publications/1-annual-meeting-american-society-of-clinical-oncology/2017-annual-meeting-american-society-of-clinical-oncology-asco/asco2017201700603final.pdf

http://postanalyst.com/2017/06/06/whats-happening-to-these-stocks-ciena-corporation-cien-ziopharm-oncology-inc-ziop/

https://www.smarteranalyst.com/2017/06/05/ziopharm-oncology-inc-ziop-announces-updated-phase-1-results-gbm/

https://www.wsj.com/articles/PR-CO-20170605-908055

Advertisements